Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.03.5352PMID 16505436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

  2005cited by this paper
• The patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience

  2004cited by this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004cited by this paper
• Outcome after local recurrence of osteosarcoma

  2004cited by this paper
• Limb sparing surgery for pediatric musculoskeletal tumors

  2004cited by this paper
• Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.

  2003cited by this paper
• Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

  2003cited by this paper
• Local control in childhood extremity sarcomas: salvaging limbs and sparing function.

  2003cited by this paper
• Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

  2003cited by this paper
• High-Grade Osteosarcoma of the Extremity: Differences Between Localized and Metastatic Tumors at Presentation

  2002cited by this paper
• Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

  2002cited by this paper
• Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?

  2002cited by this paper
• Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial

  2001cited by this paper
• A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.

  2001cited by this paper
• Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy.

  2001cited by this paper
• Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience.

  2000cited by this paper
• Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.

  2000cited by this paper
• Activity of intraarterial carboplatin as a single agent in the treatment of newly diagnosed extremity osteosarcoma.

  1999cited by this paper
• Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

  1998cited by this paper
• Tumor size and prognosis in aggressively treated osteosarcoma.

  1996cited by this paper
• A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

  1994cited by this paper
• Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

  1993cited by this paper
• Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

  1992cited by this paper
• IIB osteosarcoma. Current management, local control, and survival statistics--São Paulo, Brazil.

  1991cited by this paper
• Increased survival, limb preservation, and prognostic factors for osteosarcoma

  1991cited by this paper
• Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high‐dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS‐86)

  1990cited by this paper
• Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

  1988cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper
• Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.

  1985cited by this paper
• Bone tumors, diagnosis, treatment, and prognosis

  1979cited by this paper
• Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

  1979cited by this paper

• Delay in Diagnosis and Treatment of Bone Sarcoma—Systematic Review

  2025cites this paper
• TGF-β Induced by Allergic Lung Inflammation Enhances Os-Teosarcoma Lung Metastasis in a Mouse Comorbidity Model

  2025cites this paper
• ROLE OF POLYMORPHISMS IN VEGF AND KDR GENES IN OSTEOSARCOMA SUSCEPTIBILITY: A SYSTEMATIC REVIEW

  2025cites this paper
• -AI-assisted diagnostic potential of CT in bone oncology and its impact on clinical decision-making for intensive care

  2024cites this paper
• Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity

  2024cites this paper
• Micellar Solution of [223Ra]RaCl2: Reaching renal excretion, Potent Efficacy in Osteoblastic Osteosarcoma in PDX Model, Biochemistry Alterations and Pharmacokinetics.

  2024cites this paper
• The management of osteosarcoma in children and adolescents in a resource-limited setting: quality improvement considerations to improve treatment outcomes

  2024cites this paper
• IGFBP5 in osteosarcoma tumorigenesis: Gene expression profile among metastatic and non-metastatic patients.

  2024cites this paper
• Feasibility and stage at diagnosis for children with cancer: a pilot study on population-based data in a middle-income country using the Toronto childhood cancer stage guidelines

  2024cites this paper
• Relative Wash-In Rate in Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a New Prognostic Biomarker for Event-Free Survival in 82 Patients with Osteosarcoma: A Multicenter Study

  2024cites this paper
• Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model

  2024cites this paper
• Quantitative expression evaluation of PRAME gene in osteosarcoma

  2023cites this paper
• Impact of delay of local control in nonmetastatic extremity primary osteosarcoma

  2023cites this paper
• Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity

  2023cites this paper
• Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes

  2023cites this paper
• Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response

  2023cites this paper
• Determinants and impact of diagnostic interval in bone sarcomas: A retrospective cohort study

  2022cites this paper
• Intermediate-term results and risk factors analysis of tumor endoprosthesis in paediatric patients after the resection of lower extremity bone sarcoma

  2022cites this paper
• A Retrospective Cohort Analysis of Limb Salvage Surgery Using Mega Prosthesis in Bone Tumours at a Tertiary Care Centre in Eastern India

  2022cites this paper
• Development of a Simple Risk Model to Predict Mortality in Patients With Osteosarcoma of the Extremity

  2022cites this paper
• Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.

  2021cites this paper
• Osteosarcoma Pathogenesis Leads the Way to New Target Treatments

  2021cites this paper
• Factors Affecting Prognosis and Survival in Extremity Osteosarcoma

  2021cites this paper
• Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center

  2021cites this paper
• The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma.

  2021cites this paper
• What Effect Do Pulmonary Micronodules Detected at Presentation in Patients with Osteosarcoma Have on 5-Year Overall Survival?

  2021cites this paper
• Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?

  2021cites this paper
• Health Related Quality of Life and Depression among Blood Cancer Patients in Pakistan: The Missing Public Health Link

  2021cites this paper
• MicroRNA-382-5p inhibits osteosarcoma development and progression by negatively regulating VEZF1 expression

  2021cites this paper
• Femoral intraosseous rhabdomyosarcoma: a case report and literature review

  2021cites this paper
• A Retrospective Comparative Analysis of Outcomes and Prognostic Factors in Adult and Pediatric Patients with Osteosarcoma

  2021cites this paper
• MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration

  2021cites this paper
• Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries

  2021cites this paper
• Prognostic significance of the ratio of surgically resected to radiologically detected lung nodules in patients with metastatic osteosarcoma.

  2021cites this paper
• Clinical characteristics and prognostic factors of malignant fibrous histiocytoma of bone: a SEER population-based study

  2020cites this paper
• TRAUMA O THOPAEDIC ONCOLOGY AND INFECTIONS

  2020cites this paper
• The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes

  2020cites this paper
• Methylation of WWOX gene promotes proliferation of osteosarcoma cells.

  2020cites this paper
• Osteosarcoma: History of Therapy

  2020cites this paper
• Prognostic impact of diagnostic and treatment delays in children with osteosarcoma

  2020cites this paper
• Systemic Treatment of Conventional High-Grade Osteosarcoma

  2020cites this paper
• Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy

  2020cites this paper
• MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.

  2020cites this paper
• Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study

  2019cites this paper
• Osteosarcoma with lung metastases

  2019cites this paper
• Expression of neurotrophins and their receptors in primary osteosarcoma

  2019cites this paper
• Bone Sarcomas

  2019cites this paper
• Treatment of Children with Osteosarcoma

  2019cites this paper
• Delays in the health care system for children, adolescents, and young adults with bone tumors in Brazil.

  2019influential citation
• A polysaccharide from Enterobacter cloacae induces apoptosis of human osteosarcoma cells through the activation of p53 and mitochondrial intrinsic pathway.

  2019cites this paper
• Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

  2019cites this paper
• Treatment of Children with Osteosarcoma

  2019cites this paper
• MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma

  2019cites this paper
• Time to diagnosis of retinoblastoma in Latin America: A systematic review

  2019cites this paper
• Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.

  2019cites this paper
• Expression of neurotrophins and their receptors in primary osteosarcoma.

  2019cites this paper
• Osteosarcoma – on the way to personalized therapy. Part I: standard chemotherapy in the present

  2019cites this paper
• Characterization of Children with Non- Metastatic Osteosarcoma who Received Treatment with Mifamurtide in Two Institutions in Colombia between 2014 and 2017

  2019cites this paper
• Life and limb after limb salvage surgery for osteosarcoma in an Indian tertiary cancer center

  2019cites this paper
• Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

  2018cites this paper
• Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78

  2018cites this paper
• The extremity localized classic osteosarcomas have better survival than the axial non-classics

  2018cites this paper
• NEAT1 induces osteosarcoma development by modulating the miR‐339‐5p/TGF‐β1 pathway

  2018cites this paper
• Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma

  2018cites this paper
• Prognostic Markers in Osteosarcoma Patients in the Najaf Province of Iraq

  2018cites this paper
• A study of 853 high grade osteosarcomas from a single institution—Are outcomes in Indian patients different?

  2018influential citation
• Interested in publishing with us ? Contact book

  2018cites this paper
• The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma

  2017cites this paper
• Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy

  2017cites this paper
• A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG

  2017cites this paper
• MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2

  2017cites this paper
• Prognostic factors in the management of osteosarcoma

  2017cites this paper
• Bufalin Induces Apoptosis of Human Osteosarcoma U-2 OS Cells through Endoplasmic Reticulum Stress, Caspase- and Mitochondria-Dependent Signaling Pathways

  2017cites this paper
• Osteosarcoma periosteal desdiferenciado en la diáfisis del cúbito

  2017cites this paper
• Childhood osteosarcoma: Incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000–2013

  2017cites this paper
• Dedifferentiated parosteal osteosarcoma of the ulnar diaphysis

  2017cites this paper
• Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high‐grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment

  2017cites this paper
• Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.

  2016cites this paper
• Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model

  2016cites this paper
• Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer

  2016cites this paper
• Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.

  2016cites this paper
• Factores pronósticos de sobrevida de pacientes con osteosarcoma

  2016cites this paper
• High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients

  2016influential citation
• Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience

  2016cites this paper
• The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database

  2015cites this paper
• Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single‐center experience of 237 patients

  2015cites this paper
• Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults

  2015cites this paper
• Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

  2015cites this paper
• Experience of Pediatric Osteosarcoma of the Extremity at a Single Institution in Taiwan: Prognostic Factors and Impact on Survival

  2015cites this paper
• Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2/M checkpoint proteins.

  2015cites this paper
• Characterization of the metastatic phenotype of a panel of established osteosarcoma cells

  2015cites this paper
• Anemone altaica Induces Apoptosis in Human Osteosarcoma Cells.

  2015cites this paper
• A polysaccharide from Trametes robiniophila Murrill induces apoptosis through intrinsic mitochondrial pathway in human osteosarcoma (U-2 OS) cells

  2015cites this paper
• Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma

  2015cites this paper
• microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma

  2015cites this paper
• Original Article XB130 expression in human osteosarcoma: a clinical and experimental study

  2015cites this paper
• Osteosarcoma: A Meta-Analysis and Review of the Literature.

  2015cites this paper
• Patterns of care and outcomes of adult osteosarcoma in a tertiary care cancer centre in Pakistan.

  2014cites this paper
• Withaferin A inhibits osteosarcoma cells through inactivation of Notch-1 signalling

  2014cites this paper
• Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.

  2014cites this paper